<DOC>
	<DOCNO>NCT01978132</DOCNO>
	<brief_summary>Patients primary hyperaldosteronism experience cardiovascular event compare patient primary hypertension , independent blood pressure level . In research hypothesize patient primary hyperaldosteronism susceptible ischemia-reperfusion injury .</brief_summary>
	<brief_title>Primary Hyperaldosteronism Ischemia-reperfusion Injury</brief_title>
	<detailed_description>Patients PHA increase risk cardiovascular event , independent blood pressure level . Also patient suffer myocardial infarction , circulate aldosterone level associate increased mortality . In animal model myocardial infarction , administration exogenous aldosterone increase infarct size , although study report effect . In similar model , antagonist mineralocorticoid receptor ( MR ) reduce infarct size , completely abolish ecto-5'-nucleotidase ( CD73 , enzyme catalysis extracellular formation endogenous nucleoside adenosine ) adenosine receptor knock-out mouse . Therefore , hypothesize patient PHA increase susceptibility ischemia-reperfusion ( IR ) -injury due down-regulation enzyme CD73 . We use reduction brachial flow-mediated dilation ( FMD ) forearm IR well-validated endpoint ( endothelial ) IR-injury .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Hyperaldosteronism</mesh_term>
	<criteria>Inclusion Criteria patient primary hyperaldosteronism : Age 1875 year Confirmed primary hyperaldosteronism ( aldosterone &gt; 0.28 nmol/l salt load ) Serum potassium ≥ 3.5 mmol/L ( without potassium supplementation ) Written informed consent Inclusion Criteria patient primary hypertension : Age 1875 year Primary hypertension Baseline aldosterone &lt; 0.30 nmol/l aldosteronereninratio &lt; 0.09 Serum potassium ≥ 3.5 mmol/L Written inform consent Exclusion Criteria arm ( patient primary hyperaldosteronism patient primary hypertension : Smoking History atherosclerotic disease ( myocardial infarction ( MI ) , stroke , peripheral vascular disease ) Not possible change antihypertensive medication diltiazem without hydralazine , accord treat physician . Not possible temporarily interrupt statin treatment , patient use statin , accord treat physician . Severe renal dysfunction ( MDRD &lt; 30 ml/min ) Second/third degree AVblock electrocardiography Cardiac failure Diabetes Mellitus Use acetylsalicylic acid NSAID 's theophylline , dipyridamole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>primary hyperaldosteronism</keyword>
	<keyword>primary hypertension</keyword>
	<keyword>forearm ischemia-reperfusion</keyword>
	<keyword>( reduction ) brachial artery FMD</keyword>
	<keyword>endothelial ischemia-reperfusion injury</keyword>
</DOC>